BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28450087)

  • 1. Validity and reliability of Ki-67 assessment in oestrogen receptor positive breast cancer.
    Jing N; Fang C; Williams DS
    Pathology; 2017 Jun; 49(4):371-378. PubMed ID: 28450087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility and Prognostic Potential of Ki-67 Proliferation Index when Comparing Digital-Image Analysis with Standard Semi-Quantitative Evaluation in Breast Cancer.
    Ács B; Madaras L; Kovács KA; Micsik T; Tőkés AM; Győrffy B; Kulka J; Szász AM
    Pathol Oncol Res; 2018 Jan; 24(1):115-127. PubMed ID: 28401450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
    Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
    PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment.
    Kwon AY; Park HY; Hyeon J; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Cho SY; Cho EY
    PLoS One; 2019; 14(2):e0212309. PubMed ID: 30785924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study.
    Varga Z; Cassoly E; Li Q; Oehlschlegel C; Tapia C; Lehr HA; Klingbiel D; Thürlimann B; Ruhstaller T
    PLoS One; 2015; 10(4):e0123435. PubMed ID: 25885288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical issues concerning the implementation of Ki-67 proliferative index measurement in breast cancer reporting.
    Harvey J; Thomas C; Wood B; Hardie M; Dessauvagie B; Combrinck M; Frost FA; Sterrett G
    Pathology; 2015 Jan; 47(1):13-20. PubMed ID: 25474507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
    Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
    Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
    Serna G; Simonetti S; Fasani R; Pagliuca F; Guardia X; Gallego P; Jimenez J; Peg V; Saura C; Eppenberger-Castori S; Ramon Y Cajal S; Terracciano L; Nuciforo P
    Breast; 2020 Oct; 53():102-110. PubMed ID: 32707454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of Ki67 visual scoring app compared to eyeball estimate and digital image analysis and its prognostic significance in hormone receptor-positive breast cancer.
    Arun I; Venkatesh S; Ahmed R; Agrawal SK; Leung SCY
    APMIS; 2021 Aug; 129(8):489-502. PubMed ID: 34053140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study.
    Acs B; Pelekanou V; Bai Y; Martinez-Morilla S; Toki M; Leung SCY; Nielsen TO; Rimm DL
    Lab Invest; 2019 Jan; 99(1):107-117. PubMed ID: 30181553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
    Ayad E; Soliman A; Anis SE; Salem AB; Hu P; Dong Y
    Diagn Pathol; 2018 Aug; 13(1):63. PubMed ID: 30153851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of digital images improves reproducibility of the ki-67 labeling index as a proliferation marker in breast cancer.
    Vörös A; Csörgő E; Kővári B; Lázár P; Kelemen G; Cserni G
    Pathol Oncol Res; 2014 Apr; 20(2):391-7. PubMed ID: 24202856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer.
    Shui R; Yu B; Bi R; Yang F; Yang W
    PLoS One; 2015; 10(5):e0125131. PubMed ID: 25932921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer.
    Dawe M; Shi W; Liu TY; Lajkosz K; Shibahara Y; Gopal NEK; Geread R; Mirjahanmardi S; Wei CX; Butt S; Abdalla M; Manolescu S; Liang SB; Chadwick D; Roehrl MHA; McKee TD; Adeoye A; McCready D; Khademi A; Liu FF; Fyles A; Done SJ
    Lab Invest; 2024 May; 104(5):100341. PubMed ID: 38280634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
    Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
    Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer.
    Wang YX; Wang YY; Yang CG; Bu H; Yang WT; Wang L; Xu WM; Zhao XL; Zhao WX; Li L; Song SL; Yang JL
    Breast; 2020 Feb; 49():225-232. PubMed ID: 31911370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.
    Arihiro K; Oda M; Ohara M; Kadoya T; Osaki A; Nishisaka T; Shiroma N; Kobayashi Y
    Jpn J Clin Oncol; 2016 Dec; 46(12):1081-1087. PubMed ID: 27511992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
    Røge R; Riber-Hansen R; Nielsen S; Vyberg M
    Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.